GMAB logo

Genmab A/S (GMAB) Cash From Investing

Annual CFI

-$186.13 M
+$205.27 M+52.45%

December 31, 2023


Summary


Performance

GMAB Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

Quarterly CFI

$2.09 M
+$1.27 B+100.17%

September 1, 2024


Summary


Performance

GMAB Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

TTM CFI

-$1.54 B
-$145.33 M-10.45%

September 1, 2024


Summary


Performance

GMAB TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GMAB Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+52.5%-98.6%-867.6%
3 y3 years+48.3%+211.6%-424.7%
5 y5 years+33.9%+211.6%-424.7%

GMAB Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.7%+52.5%-98.6%+100.2%-904.2%at low
5 y5-year-21.7%+52.5%-99.2%+100.2%-3552.7%at low
alltimeall time-202.0%+57.2%-99.2%+100.2%-795.0%at low

Genmab A/S Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.09 M(-100.2%)
-$1.54 B(+10.5%)
Jun 2024
-
-$1.26 B(+502.4%)
-$1.39 B(+252.7%)
Mar 2024
-
-$209.89 M(+230.7%)
-$394.15 M(+111.8%)
Dec 2023
-$186.13 M(-52.4%)
-$63.46 M(-143.0%)
-$186.13 M(+17.3%)
Sep 2023
-
$147.42 M(-155.0%)
-$158.69 M(-67.2%)
Jun 2023
-
-$268.22 M(>+9900.0%)
-$483.55 M(+65.2%)
Mar 2023
-
-$1.87 M(-94.8%)
-$292.66 M(-25.2%)
Dec 2022
-$391.40 M(+156.0%)
-$36.02 M(-79.7%)
-$391.40 M(-3.2%)
Sep 2022
-
-$177.43 M(+129.4%)
-$404.45 M(-17.0%)
Jun 2022
-
-$77.33 M(-23.1%)
-$487.42 M(+205.3%)
Mar 2022
-
-$100.62 M(+105.0%)
-$159.67 M(+4.4%)
Dec 2021
-$152.92 M(-57.5%)
-$49.07 M(-81.2%)
-$152.92 M(-26.1%)
Sep 2021
-
-$260.40 M(-204.0%)
-$206.90 M(-39.3%)
Jun 2021
-
$250.41 M(-366.8%)
-$340.72 M(-25.2%)
Mar 2021
-
-$93.86 M(-8.9%)
-$455.41 M(+26.4%)
Dec 2020
-$360.22 M(+21.1%)
-$103.06 M(-73.9%)
-$360.22 M(-16.3%)
Sep 2020
-
-$394.21 M(-390.5%)
-$430.56 M(+924.2%)
Jun 2020
-
$135.72 M(>+9900.0%)
-$42.04 M(-85.7%)
Mar 2020
-
$1.33 M(-100.8%)
-$293.88 M(-1.2%)
Dec 2019
-$297.34 M(+5.6%)
-$173.40 M(+2947.1%)
-$297.34 M(+36.2%)
Sep 2019
-
-$5.69 M(-95.1%)
-$218.29 M(-20.3%)
Jun 2019
-
-$116.12 M(+5349.9%)
-$273.84 M(+60.0%)
Mar 2019
-
-$2.13 M(-97.7%)
-$171.14 M(-39.2%)
Dec 2018
-$281.65 M(+177.0%)
-$94.35 M(+54.0%)
-$281.65 M(+57.1%)
Sep 2018
-
-$61.25 M(+356.6%)
-$179.29 M(+47.8%)
Jun 2018
-
-$13.42 M(-88.1%)
-$121.34 M(-23.6%)
Mar 2018
-
-$112.64 M(-1505.6%)
-$158.85 M(+56.2%)
Dec 2017
-$101.68 M(-32.6%)
$8.01 M(-342.9%)
-$101.68 M(-43.6%)
Sep 2017
-
-$3.30 M(-93.5%)
-$180.31 M(-0.4%)
Jun 2017
-
-$50.92 M(-8.2%)
-$180.98 M(+6.4%)
Mar 2017
-
-$55.47 M(-21.4%)
-$170.07 M(+12.8%)
Dec 2016
-$150.80 M(+110.8%)
-$70.62 M(+1678.3%)
-$150.80 M(+83.6%)
Sep 2016
-
-$3.97 M(-90.1%)
-$82.15 M(-3.1%)
Jun 2016
-
-$40.01 M(+10.5%)
-$84.73 M(+46.1%)
Mar 2016
-
-$36.20 M(+1739.9%)
-$58.01 M(-18.9%)
DateAnnualQuarterlyTTM
Dec 2015
-$71.54 M(-60.3%)
-$1.97 M(-70.0%)
-$71.54 M(+16.7%)
Sep 2015
-
-$6.56 M(-50.7%)
-$61.29 M(-34.7%)
Jun 2015
-
-$13.29 M(-73.3%)
-$93.89 M(-34.3%)
Mar 2015
-
-$49.73 M(-700.0%)
-$142.90 M(-20.7%)
Dec 2014
-$180.26 M(-1612.1%)
$8.29 M(-121.2%)
-$180.26 M(+2.8%)
Sep 2014
-
-$39.16 M(-37.1%)
-$175.34 M(+12.2%)
Jun 2014
-
-$62.30 M(-28.5%)
-$156.29 M(+61.9%)
Mar 2014
-
-$87.09 M(-759.5%)
-$96.54 M(-909.8%)
Dec 2013
$11.92 M(-116.6%)
$13.20 M(-165.7%)
$11.92 M(-110.3%)
Sep 2013
-
-$20.11 M(+688.9%)
-$116.29 M(+29.3%)
Jun 2013
-
-$2.55 M(-111.9%)
-$89.92 M(+23.6%)
Mar 2013
-
$21.37 M(-118.6%)
-$72.73 M(+1.2%)
Dec 2012
-$71.90 M(-174.8%)
-$115.01 M(-1936.1%)
-$71.90 M(-262.7%)
Sep 2012
-
$6.26 M(-57.2%)
$44.20 M(-37.4%)
Jun 2012
-
$14.64 M(-34.1%)
$70.56 M(-16.0%)
Mar 2012
-
$22.21 M(+1934.6%)
$84.01 M(-12.6%)
Dec 2011
$96.16 M(-173.1%)
$1.09 M(-96.7%)
$96.16 M(+130.1%)
Sep 2011
-
$32.62 M(+16.1%)
$41.78 M(-132.9%)
Jun 2011
-
$28.09 M(-18.2%)
-$127.13 M(+25.2%)
Mar 2011
-
$34.35 M(-164.5%)
-$101.51 M(-22.8%)
Dec 2010
-$131.47 M(-172.1%)
-$53.28 M(-60.9%)
-$131.47 M(+12.6%)
Sep 2010
-
-$136.29 M(-353.8%)
-$116.72 M(-171.8%)
Jun 2010
-
$53.71 M(+1122.8%)
$162.64 M(+48.6%)
Mar 2010
-
$4.39 M(-111.4%)
$109.41 M(-40.0%)
Dec 2009
$182.42 M(+101.3%)
-$38.53 M(-126.9%)
$182.42 M(-17.4%)
Sep 2009
-
$143.07 M(>+9900.0%)
$220.94 M(+183.7%)
Jun 2009
-
$481.80 K(-99.4%)
$77.88 M(+0.6%)
Mar 2009
-
$77.40 M
$77.40 M
Dec 2008
$90.64 M(-120.9%)
-
-
Dec 2007
-$434.53 M(+471.6%)
-
-
Dec 2006
-$76.02 M(+256.8%)
-
-
Dec 2005
-$21.30 M(+408.2%)
-
-
Dec 2004
-$4.19 M(-107.6%)
-
-
Dec 2003
$55.09 M(+81.5%)
-
-
Dec 2002
$30.36 M
-
-

FAQ

  • What is Genmab A/S annual cash flow from investing activities?
  • What is the all time high annual CFI for Genmab A/S?
  • What is Genmab A/S annual CFI year-on-year change?
  • What is Genmab A/S quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Genmab A/S?
  • What is Genmab A/S quarterly CFI year-on-year change?
  • What is Genmab A/S TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Genmab A/S?
  • What is Genmab A/S TTM CFI year-on-year change?

What is Genmab A/S annual cash flow from investing activities?

The current annual CFI of GMAB is -$186.13 M

What is the all time high annual CFI for Genmab A/S?

Genmab A/S all-time high annual cash flow from investing activities is $182.42 M

What is Genmab A/S annual CFI year-on-year change?

Over the past year, GMAB annual cash flow from investing activities has changed by +$205.27 M (+52.45%)

What is Genmab A/S quarterly cash flow from investing activities?

The current quarterly CFI of GMAB is $2.09 M

What is the all time high quarterly CFI for Genmab A/S?

Genmab A/S all-time high quarterly cash flow from investing activities is $250.41 M

What is Genmab A/S quarterly CFI year-on-year change?

Over the past year, GMAB quarterly cash flow from investing activities has changed by -$145.33 M (-98.58%)

What is Genmab A/S TTM cash flow from investing activities?

The current TTM CFI of GMAB is -$1.54 B

What is the all time high TTM CFI for Genmab A/S?

Genmab A/S all-time high TTM cash flow from investing activities is $220.94 M

What is Genmab A/S TTM CFI year-on-year change?

Over the past year, GMAB TTM cash flow from investing activities has changed by -$1.38 B (-867.65%)